Glucocapparin potassium
Glucocapparin (Methyl glucosinolate) potassium is a glucosinolate compound. Glucocapparin potassium can be isolated from plants of the Brassicaceae and Capparaceae families. Glucocapparin potassium possesses phytochemical defense (insect-repellent and antibacterial), hypoglycemic and antioxidant activities, and the isothiocyanate substances produced by its hydrolysis exhibit certain anticancer effects. Glucocapparin potassium can be used in studies related to cancer, inflammation and hyperglycemia.
For research use only. We do not sell to patients.
- CAS No.: 15592-33-3
- Formula: C8H14KNO9S2
- Molecular Weight:371.43
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
All Endogenous Metabolite Isoforms
More
Biological Activity
Description
Chemical Information
-
CAS No. 15592-33-3
-
Molecular Weight 371.43
-
Formula C8H14KNO9S2
-
SMILES
O[C@H]1[C@H](S/C(C)=N/OS(=O)(O[K])=O)O[C@H](CO)[C@@H](O)[C@@H]1O
-
Synonyms
Methyl glucosinolate potassium
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Glucocapparin potassium Related Classifications
HY-N21949A Related Classifications
Powered by Bioz